Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Julieta Lazarte & Robert A. Hegele. (2021) Volanesorsen for treatment of familial chylomicronemia syndrome. Expert Review of Cardiovascular Therapy 19:8, pages 685-693.
Read now
Read now
Oluwayemisi Esan & Anthony S Wierzbicki. (2020) Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy. Drug Design, Development and Therapy 14, pages 2623-2636.
Read now
Read now
Articles from other publishers (21)
John P. Cooke & Keith A. Youker. (2022) Future Impact of mRNA Therapy on Cardiovascular Diseases. Methodist DeBakey Cardiovascular Journal 18:5, pages 64-73.
Crossref
Crossref
Ruoyu Chen, Shaoyi Lin & Xiaomin Chen. (2022) The promising novel therapies for familial hypercholesterolemia. Journal of Clinical Laboratory Analysis 36:7.
Crossref
Crossref
Jing Wang, Qianqian Xiao, Luyun Wang, Yan Wang, Daowen Wang & Hu Ding. (2022) Role of ABCA1 in Cardiovascular Disease. Journal of Personalized Medicine 12:6, pages 1010.
Crossref
Crossref
Sangkyu Noh, Kevin Mai, Madeleine Shaver, Stanley Yong, Mirko Mostaghimi, Grace Oh & Mohamed M. Radwan. (2022) Emerging Cholesterol Modulators for Atherosclerotic Cardiovascular Disease. The American Journal of the Medical Sciences 363:5, pages 373-387.
Crossref
Crossref
Christian Boada, Roman Sukhovershin, Roderic Pettigrew & John P. Cooke. (2021) RNA therapeutics for cardiovascular disease. Current Opinion in Cardiology 36:3, pages 256-263.
Crossref
Crossref
Eun Ji Kim & Anthony S. Wierzbicki. (2020) The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease. Therapeutic Advances in Chronic Disease 11, pages 204062232092456.
Crossref
Crossref
C. Macchi, C.R. Sirtori, A. Corsini, R.D. Santos, G.F. Watts & M. Ruscica. (2019) A new dawn for managing dyslipidemias: The era of rna-based therapies. Pharmacological Research 150, pages 104413.
Crossref
Crossref
Anne Langsted & Børge G. Nordestgaard. (2019) Antisense Oligonucleotides Targeting Lipoprotein(a). Current Atherosclerosis Reports 21:8.
Crossref
Crossref
Toshiyuki Nishikido & Kausik K. Ray. (2019) Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries. Frontiers in Cardiovascular Medicine 5.
Crossref
Crossref
Alfred Adiamah, Emmanouil Psaltis, Martin Crook & Dileep N. Lobo. (2018) A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis. Clinical Nutrition 37:6, pages 1810-1822.
Crossref
Crossref
A.S. Levina, M.N. Repkova, Z.R. Ismagilov & V.F. Zarytova. (2018) Methods of the Synthesis of Silicon-Containing Nanoparticles Intended for Nucleic Acid Delivery. Eurasian Chemico-Technological Journal 20:3, pages 177.
Crossref
Crossref
A. S. Wierzbicki. (2018) Further options for treating lipids in people with diabetes: targeting LDL-cholesterol and beyond. Diabetic Medicine 35:9, pages 1173-1180.
Crossref
Crossref
James M. Falko. (2018) Familial Chylomicronemia Syndrome: A Clinical Guide for Endocrinologists. Endocrine Practice 24:8, pages 756-763.
Crossref
Crossref
Anthony S. Wierzbicki, Timothy M. Reynolds & Adie Viljoen. (2018) An update on trials of novel lipid-lowering drugs. Current Opinion in Cardiology 33:4, pages 416-422.
Crossref
Crossref
Allyson L Mayer, Yiming Zhang, Emily H Feng, Cassandra B Higgins, Oyinkansola Adenekan, Terri A Pietka, Wandy L Beatty & Brian J DeBosch. (2018) Enhanced Hepatic PPARα Activity Links GLUT8 Deficiency to Augmented Peripheral Fasting Responses in Male Mice. Endocrinology 159:5, pages 2110-2126.
Crossref
Crossref
Børge G. Nordestgaard, Stephen J. Nicholls, Anne Langsted, Kausik K. Ray & Anne Tybjærg-Hansen. (2018) Advances in lipid-lowering therapy through gene-silencing technologies. Nature Reviews Cardiology 15:5, pages 261-272.
Crossref
Crossref
Anthony C. Keech & Alicia J. Jenkins. (2017) Triglyceride-lowering trials. Current Opinion in Lipidology 28:6, pages 477-487.
Crossref
Crossref
Grace T. Kwok, Jing Ting Zhao, Jocelyn Weiss, Nancy Mugridge, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Bruce G. Robinson & Stan B. Sidhu. (2017) Translational applications of microRNAs in cancer, and therapeutic implications. Non-coding RNA Research 2:3-4, pages 143-150.
Crossref
Crossref
Željko Reiner. (2017) Hypertriglyceridaemia and risk of coronary artery disease. Nature Reviews Cardiology 14:7, pages 401-411.
Crossref
Crossref
K. G. Parhofer. (2017) Diabetes Update 2017 – LipideDiabetes update 2017 – lipids. Der Diabetologe 13:5, pages 313-321.
Crossref
Crossref
Wenzhang Cha, Rengen Fan, Yufeng Miao, Yong Zhou, Chenglin Qin, Xiangxiang Shan, Xinqiang Wan & Jinbo Li. (2017) Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications. Molecules 22:5, pages 782.
Crossref
Crossref